Protective effects of berberine in an experimental rat osteoarthritis model

Phytotherapy Research

Volumn 25, Issue 6, 2011, Pages 878-885

  Hu, Peng Fei ^a   Chen, Wei Ping ^a   Tang, Jing Li ^a   Bao, Jia Peng ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

berberine; interleukin 1 beta; matrix metalloproteinase; osteoarthritis

Indexed keywords

BERBERINE; COLLAGENASE 3; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; PROTEOGLYCAN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME RELEASE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BERBERINE; CARTILAGE, ARTICULAR; CELL PROLIFERATION; CHONDROCYTES; DNA PRIMERS; GENE EXPRESSION REGULATION; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; OSTEOARTHRITIS; PLANT EXTRACTS; PROTECTIVE AGENTS; PROTEOGLYCANS; RATS; RNA, MESSENGER;

RATTUS;

EID: 79957830383     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3359     Document Type: Article

References (40)

1. Aida Y, Maeno M, Suzuki N, Shiratsuchi H, Motohashi M, Matsumura H,. 2005. The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sci 77: 3210-3221. (Pubitemid 41433321)
2. Aigner T, McKenna L,. 2002. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci 59: 5-18. (Pubitemid 34117351)
3. Amin AH, Subbaiah TV, Abbasi KM,. 1969. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 15: 1067-1076.
4. Bao JP, Chen WP, Feng J, Hu PF, Shi ZL, Wu LD,. 2010. Leptin plays a catabolic role on articular cartilage. Mol Biol Rep 37: 3265-3272.
5. Birkedal-Hansen H, Moore WG, Bodden MK, et al. 1993. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250. (Pubitemid 23103292)
6. Bonnet CS, Walsh DA,. 2005. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44: 7-16. (Pubitemid 40136474)
7. Burrage PS, Mix KS, Brinckerhoff CE,. 2006. Matrix metalloproteinases: role in arthritis. Front Biosci 11: 529-543. (Pubitemid 43258162)
8. Case JP, Baliunas AJ, Block JA,. 2003. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 163: 169-178. (Pubitemid 36120185)
9. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr., 1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84: 678-685. (Pubitemid 19197004)
10. Farndale RW, Sayers CA, Barrett AJ,. 1982. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9: 247-248. (Pubitemid 12009669)
11. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA,. 1997. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 56: 542-549. (Pubitemid 27428477)
12. Goupille P, Jayson MI, Valat JP, Freemont AJ,. 1998. Matrix metalloproteinases: the clue to intervertebral disc degeneration? Spine (Phila Pa 1976) 23: 1612-1626. (Pubitemid 28459968)
13. Gouze JN, Bordji K, Gulberti S, et al. 2001. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum 44: 351-360.
14. Gouze JN, Gouze E, Palmer GD, et al. 2004. Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1beta on rat chondrocytes. Osteoarthritis Cartilage 12: 217-224. (Pubitemid 38248070)
15. Gouze JN, Gouze E, Popp MP, et al. 2006. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta. Arthritis Res Ther 8: R173.
16. Henrotin Y, Kurz B, Aigner T,. 2005. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 13: 643-654. (Pubitemid 41025117)
17. Hu Y, Chen X, Duan H, Mu X,. 2009. Pulsatilla decoction and its active ingredients inhibit secretion of NO, ET-1, TNF-alpha, and IL-1 alpha in LPS-induced rat intestinal microvascular endothelial cells. Cell Biochem Funct 27: 284-288.
18. Huang Z, Wang L, Meng S, Wang Y, Chen T, Wang C,. 2009. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages. Int J Cardiol doi:10.1016/j.ijcard.2009.06.023.
19. Ikram M,. 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353-358.
20. Jo H, Park JS, Kim EM, et al. 2003. The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11: 585-594. (Pubitemid 36926534)
21. Kanyama M, Kuboki T, Kojima S, et al. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. J Orofac Pain 14: 20-30.
22. Karsdal MA, Madsen SH, Christiansen C, Henriksen K, Fosang AJ, Sondergaard BC,. 2008. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther 10: R63.
23. Kim JB, Lee KM, Ko E, et al. 2008a. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 74: 39-42. (Pubitemid 351251381)
24. Kim S, Choi JH, Kim JB, et al. 2008b. Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13: 2975-2985.
25. Kim S, Chung JH,. 2008. Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts. Phytomedicine 15: 749-753.
26. Kim S, Kim Y, Kim JE, Cho KH, Chung JH,. 2008c. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15: 340-347. (Pubitemid 351508395)
27. Kobayashi M, Squires GR, Mousa A, et al. 2005. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52: 128-135. (Pubitemid 40129241)
28. Kuo CL, Chi CW, Liu TY,. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203: 127-137.
29. Lin JP, Yang JS, Wu CC, et al. 2008. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro. In Vivo 22: 223-230.
30. Little CB, Barai A, Burkhardt D, et al. 2009. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60: 3723-3733.
31. Maneiro E, Lopez-Armada MJ, de Andres MC, et al. 2005. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis 64: 388-395. (Pubitemid 40283048)
32. Mankin HJ, Dorfman H, Lippiello L, Zarins A,. 1971. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53: 523-537.
33. Mathy-Hartert M, Jacquemond-Collet I, Priem F, Sanchez C, Lambert C, Henrotin Y,. 2009. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res 58: 899-908.
34. Misik V, Bezakova L, Malekova L, Kostalova D,. 1995. Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. Planta Med 61: 372-373.
35. Nethery A, Giles I, Jenkins K, et al. 1992. The chondroprotective drugs, Arteparon and sodium pentosan polysulphate, increase collagenase activity and inhibit stromelysin activity in vitro. Biochem Pharmacol 44: 1549-1553.
36. Neuhold LA, Killar L, Zhao W, et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 107: 35-44. (Pubitemid 32047412)
37. Scott I, Midha A, Rashid U, et al. 2009. Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1beta-driven model of joint pathology. Osteoarthritis Cartilage 17: 790-797.
38. Ye M, Fu S, Pi R, He F,. 2009. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol 61: 831-837.
39. Yoshihara Y, Nakamura H, Obata K, et al. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59: 455-461. (Pubitemid 30395603)
40. Zhou PH, Liu SQ, Peng H,. 2008. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 26: 1643-1648.